Abstract
Nin one binding-1 protein (NOB1) is a kind of zinc protein involved in ribosome biogenesis and controlled proteolysis. To explore the function of NOB1 in human prostate malignancy, we analyzed the expression of NOB1 in prostate cancer and found that NOB1 was elevated in prostate cancer tissues compared to the adjacent normal tissues. Knockdown of NOB1 by lentivirus-shRNA inhibited the proliferation and colony-formation ability of PC-3 and DU145 prostate cancer cells. Cell cycle analysis showed that silencing of NOB1 caused G0/G1 phase arrest and a slight decrease in S phase (P < 0.05). Furthermore, knockdown of NOB1 significantly suppressed the mobility of PC-3 and DU145 prostate cancer cells (P < 0.05). Collectively, these findings suggested that NOB1 might be involved in tumorigenecity of prostate cancer, and could be a potential molecular target for prostate cancer gene therapy.
Similar content being viewed by others
References
Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29. doi:10.3322/caac.21208
Vallo S, Mani J, Stastny M, Makarevic J, Juengel E, Tsaur I, Bartsch G, Haferkamp A, Blaheta RA (2013) The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258. Invest New Drugs 31:265–272. doi:10.1007/s10637-012-9851-5
Walczak JR, Carducci MA (2007) Prostate cancer: a practical approach to current management of recurrent disease. Mayo Clin Proc 82:243–249. doi:10.4065/82.2.243
Petrylak D (2005) Therapeutic options in androgen-independent prostate cancer: building on docetaxel. BJU Int 96(Suppl 2):41–46. doi:10.1111/j.1464-410X.2005.05946.x
Roy M, Kung HJ, Ghosh PM (2011) Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteins. Am J Cancer Res 1:542–561
Tone Y, Tanahashi N, Tanaka K, Fujimuro M, Yokosawa H, Toh-e A (2000) Nob1p, a new essential protein, associates with the 26S proteasome of growing Saccharomyces cerevisiae cells. Gene 243:37–45
Lin Y, Peng S, Yu H, Teng H, Cui M (2012) RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells. Med Oncol 29:311–317. doi:10.1007/s12032-010-9808-5
Fatica A, Oeffinger M, Dlakic M, Tollervey D (2003) Nob1p is required for cleavage of the 3′ end of 18S rRNA. Mol Cell Biol 23:1798–1807
Lamanna AC, Karbstein K (2009) Nob1 binds the single-stranded cleavage site D at the 3′-end of 18S rRNA with its PIN domain. Proc Natl Acad Sci USA 106:14259–14264. doi:10.1073/pnas.0905403106
Strunk BS, Loucks CR, Su M, Vashisth H, Cheng S, Schilling J, Brooks CL 3rd, Karbstein K, Skiniotis G (2011) Ribosome assembly factors prevent premature translation initiation by 40S assembly intermediates. Science 333:1449–1453. doi:10.1126/science.1208245
Wang Z, Chen J, Sun J, Cui Z, Wu H (2012) RNA interference-mediated silencing of eukaryotic translation initiation factor 3, subunit B (EIF3B) gene expression inhibits proliferation of colon cancer cells. World J Surg Oncol 10:119. doi:10.1186/1477-7819-10-119
He XW, Tao F, Luo SS, Yu XK (2012) Effect of lentivirus-mediated NOB1 gene silencing by RNA interference on proliferation and apoptosis of human colon cancer cells. Zhonghua Wei Chang Wai Ke Za Zhi 15:1182–1186
Huang WY, Chen DH, Ning L, Wang LW (2012) siRNA mediated silencing of NIN1/RPN12 binding protein 1 homolog inhibits proliferation and growth of breast cancer cells. Asian Pac J Cancer Prev 13:1823–1827
Lu Z, Guo Q, Shi A, Xie F, Lu Q (2012) Downregulation of NIN/RPN12 binding protein inhibit the growth of human hepatocellular carcinoma cells. Mol Biol Rep 39:501–507. doi:10.1007/s11033-011-0764-8
Che JP, Li W, Yan Y, Liu M, Wang GC, Li QY, Yang B, Yao XD, Zheng JH (2013) Expression and clinical significance of the nin one binding protein and p38 MAPK in prostate carcinoma. Int J Clin Exp Pathol 6:2300–2311
Graca I, Sousa EJ, Costa-Pinheiro P, Vieira FQ, Torres-Ferreira J, Martins MG, Henrique R, Jeronimo C (2014) Anti-neoplastic properties of hydralazine in prostate cancer. Oncotarget 5:5950–5964
Tone Y, Toh EA (2002) Nob1p is required for biogenesis of the 26S proteasome and degraded upon its maturation in Saccharomyces cerevisiae. Genes Dev 16:3142–3157. doi:10.1101/gad.1025602
Diaz-Moralli S, Tarrado-Castellarnau M, Miranda A, Cascante M (2013) Targeting cell cycle regulation in cancer therapy. Pharmacol Ther 138:255–271. doi:10.1016/j.pharmthera.2013.01.011
Zhang Y, Ni J, Zhou G, Yuan J, Ren W, Shan Y, Tang W, Yu L, Zhao S (2005) Cloning, expression and characterization of the human NOB1 gene. Mol Biol Rep 32:185–189. doi:10.1007/s11033-005-3141-7
Veith T, Martin R, Wurm JP, Weis BL, Duchardt-Ferner E, Safferthal C, Hennig R, Mirus O, Bohnsack MT, Wohnert J, Schleiff E (2012) Structural and functional analysis of the archaeal endonuclease Nob1. Nucleic Acids Res 40:3259–3274. doi:10.1093/nar/gkr1186
Missbach S, Weis BL, Martin R, Simm S, Bohnsack MT, Schleiff E (2013) 40S ribosome biogenesis co-factors are essential for gametophyte and embryo development. PLoS ONE 8:e54084. doi:10.1371/journal.pone.0054084
Omlin A, de Bono JS (2012) Therapeutic options for advanced prostate cancer: 2011 update. Curr Urol Rep 13:170–178. doi:10.1007/s11934-012-0239-z
Acknowledgments
This work was supported by grants from National Natural Science Foundation of China (Nos. 30973006, 81170637), National Natural Science Foundation of China for Youths (Nos. 81001136 and 81202020), Shanghai Committee of Science and Technology General Program for Medicine (No. 11JC1402302), Key Project of Science and Innovation Foundation of Shanghai Ministry of Education (14zz084), and Military Fund for Health Care (13BJZ29).
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Fig. 1
Tumorigenesis in nude mice. DU145 cells were transducted with Lv-shcon or Lv-shNOB1. Cell suspensions (200 µL) were subcutaneously injected at a density of 5 × 107/mL into nude mice, and the tumor volumes were monitored at the indicated intervals (A). Tumor volume was calculated with the formula V = (a 2 × b)/2 where a is the width of the tumor (small diameter), and b the length (large diameter), both in millimeters. At day 26, the mice were sacrificed and the tumors were isolated (C). Tumor weights were detected (B). (JPEG 46 kb)
Supplementary Fig. 2
NOB1 knockdown did not significantly influence the apoptosis of prostate cancer cells. (JPEG 43 kb)
Supplementary Fig. 3
The original data of flow cytometry analysis of cell cycle distribution after NOB1 knockdown. (JPEG 138 kb)
Rights and permissions
About this article
Cite this article
Zhang, X., Zhang, D., Qu, F. et al. Knockdown of NOB1 expression inhibits the malignant transformation of human prostate cancer cells. Mol Cell Biochem 396, 1–8 (2014). https://doi.org/10.1007/s11010-014-2126-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-014-2126-z